Microvue C3 activation, microvue C5A and sclerostin high sensitivity
Ended Awarded Last action
- Contract number
- HT001419F0105
- Awardee
-
Quidel Corp UEI VNAKZRHYAUC7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $52,060
Award facts
- Contract value 100% obligated
- $52,060.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$37,940 | |
| Other Administrative Action | -$10,000 | |
| Original award | $100,000 |
Quick answers
Who was awarded contract HT001419F0105?
HT001419F0105 was awarded to Quidel Corp by Defense Health Agency (Department of Defense) on December 17, 2018.
How much is contract HT001419F0105 worth?
The government has obligated $52,060 on HT001419F0105.
Is contract HT001419F0105 an order under another contract?
Yes. HT001419F0105 is a BPA call under HT001415A0127, a blanket purchase agreement.
Was contract HT001419F0105 competed?
The extent of competition for HT001419F0105 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award